Skip to content
Clinical Trials – home
LithuaniaBack to Lithuania

Clinical trials in Kaunas – page 4

174 clinical trials in Kaunas, Lithuania across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

LithuaniaOur site in LithuaniaKlinikiniai-Tyrimai.lt(opens in a new tab)
Kaunas at a glance
174
clinical trials
  • Research sites3
Type of trial
Recruitment status
Quick filters

174 trials in Kaunas

Open in trial search

Study on JX10 for Improving Outcomes in Patients with Acute Ischemic Stroke

Investigational
Countries:LithuaniaLithuania
  • Participants:18–64 years · 65+ years
  • Substances:JX10
  • Sponsor:Corxel Pharmaceuticals Co. Ltd.

Study on Ferric Derisomaltose for Patients with Iron Deficiency and Chronic Heart Failure

Registered drugNo placebo
Countries:LithuaniaLithuania
  • Participants:18–64 years · 65+ years
  • Substances:Ferric Derisomaltose
  • Sponsor:Pharmacosmos A/S

Study of L-Annamycin and Cytarabine for Adults with Refractory or Relapsed Acute Myeloid Leukemia

Registered drug
Countries:LithuaniaLithuania
  • Participants:18–64 years · 65+ years
  • Substances:Annamycin
  • Sponsor:Moleculin Biotech Inc.

Study on the Effectiveness and Safety of Efgartigimod PH20 SC for Adults with Systemic Sclerosis

Registered drug
Countries:LithuaniaLithuania
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx

Anaemia+1

Recruiting

Study of Elritercept for Treating Anemia in Adults with Low to Intermediate Risk Myelodysplastic Syndromes

Investigational
Countries:LithuaniaLithuania
  • Participants:18–64 years · 65+ years
  • Substances:Elritercept
  • Sponsor:Takeda Development Center Americas Inc.

Lupus nephritis

Recruiting

Study on the Effects and Safety of Ianalumab in Adults with Lupus Nephritis Who Completed Previous Treatment

Registered drugNo placebo
Countries:LithuaniaLithuania
  • Participants:18–64 years · 65+ years
  • Substances:Emtricitabine
  • Sponsor:Novartis Pharma AG

Study on the Effectiveness of Gilteritinib and Drug Combination for Patients with Relapsed or Refractory Acute Myeloid Leukemia

Registered drugNo placebo
Countries:LithuaniaLithuania
  • Participants:18–64 years · 65+ years
  • Substances:Amsacrine
  • Sponsor:Istituto Romagnolo Per Lo Studio Dei Tumori Dino Amadori IRST S.r.l.

Study on the Safety and Effectiveness of Vibegron for Children Aged 2 to 17 with Neurogenic Bladder Overactivity Using Clean Intermittent Catheterization

InvestigationalNo placebo
Countries:LithuaniaLithuania
  • Participants:0–17 years
  • Substances:Vibegron
  • Sponsor:Sumitomo Pharma America Inc.

Study on Antithrombin III Human for Patients with Heparin Resistance Undergoing Cardiac Surgery with Cardiopulmonary Bypass

Registered drug
Countries:LithuaniaLithuania
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Octapharma AG

Cystic fibrosis

Recruiting

Study on the Safety and Effects of SPL84 for Patients with Cystic Fibrosis

Investigational
Countries:LithuaniaLithuania
  • Participants:18–64 years · 65+ years
  • Sponsor:Splisense Ltd.

Study comparing ferumoxytol and iron sucrose for treating iron deficiency anemia in children

Registered drugNo placebo
Countries:LithuaniaLithuania
  • Participants:0–17 years
  • Substances:Ferumoxytol
  • Sponsor:Amag Pharmaceuticals Inc.

Study on Lumateperone for Patients with Major Depressive Disorder Not Responding to Antidepressants

Investigational
Countries:LithuaniaLithuania
  • Participants:18–64 years · 65+ years
  • Substances:Lumateperone
  • Sponsor:Intra-Cellular Therapies Inc.

Other cities in Lithuania

The busiest research cities in the country

All 10 cities in Lithuania

Clinical research in Kaunas

What the registry says about research in the country

01 Oncology Research

Groundbreaking studies focusing on acute myeloid leukemia, various types of lung cancer, and bladder cancer treatments. Research includes innovative combination therapies and novel drug applications.

  • Advanced NSCLC Treatments
  • Leukemia Therapies
  • Bladder Cancer Interventions

Emphasis on both early-stage and metastatic disease management.

02 Autoimmune Disorders

Clinical investigations targeting systemic sclerosis, ulcerative colitis, and Crohn's disease. Studies evaluate new biological therapies and disease-modifying treatments.

  • Inflammatory Bowel Diseases
  • Systemic Lupus Erythematosus
  • Rheumatoid Arthritis

Focus on improving quality of life and disease management.

03 Preventive Medicine

Research into preventive healthcare including influenza vaccines and contraceptive methods. Studies examine both pediatric and adult populations.

  • Vaccine Development
  • Contraceptive Technologies
  • Immunization Studies

Emphasis on safety and long-term effectiveness.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.